1.
Yehudai-Ofir D, Khatib H, Beyar-Katz O, Frisch A, Krayem B, Zuckerman T, Henig I. Favorable safety and efficacy profiles of α-1-antitrypsin in steroid- and ruxolitinib-refractory acute graft-versus-host disease of the gastrointestinal tract: a retrospective, single center study. Haematologica; https://doi.org/10.3324/haematol.2026.300541 [Early view].